The endocannabinoid signalling system: biochemical aspects.
paper
Cited
Public
Unavailable
- Authors
- Bisogno, Tiziana; Ligresti, Alessia; Di Marzo, Vincenzo
- Year
- 2005
- Journal
- Pharmacology, biochemistry, and behavior
- PMID
- 15935454
- DOI
- 10.1016/j.pbb.2005.01.027
Knowledge of the endogenous cannabinoid system has expanded greatly during the past years. After the discovery of the cannabinoid receptors, of their endogenous agonists and of the proteins for their synthesis and inactivation, significant progress has been made towards the understanding of the role of the endocannabinoid system in vital functions. Subsequently, an increasing number of papers has been published on the biochemistry and pharmacology of endocannabinoids. This article overviews the endocannabinoid signalling system with focus on its biochemical aspects. In particular we review the mechanisms for the biosynthesis and inactivation of the endocannabinoids, as well as the various molecular targets for some of the endocannabinoids described so far.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Endocannabinoid dysregulation and PTSD in urban adolescents: Associations with anandamide concentrations and FAAH genotype. | Marusak HA et al. | β | 2026 | β |
| Cannabinoids Activate Endoplasmic Reticulum Stress Response and Promote the Death of Avian Retinal MΓΌller Cells in Culture. | Ventura ALM et al. | β | 2025 | β |
| Substrate-selective COX-2 inhibition by IMMA attenuates posttraumatic headache via endocannabinoid modulation and neuroinflammatory suppression. | Wen J et al. | β | 2025 | β |
| The Endocannabinoid System: Role in Ocular Physiology and Therapeutic Potential in Eye Diseases: A Narrative Review. | Feki O et al. | β | 2025 | β |
| Cannabinoids as multifaceted compounds. | Persia D et al. | β | 2023 | β |
| Effects of microencapsulated blend of organic acids and botanicals on growth performance, intestinal barrier function, inflammatory cytokines, and endocannabinoid system gene expression in broiler chickens. | Bialkowski S et al. | β | 2023 | β |
| Renal Endocannabinoid Dysregulation in Obesity-Induced Chronic Kidney Disease in Humans. | Permyakova A et al. | β | 2023 | β |
| The Interplay between Cannabinoid Receptors and Microglia in the Pathophysiology of Alzheimer's Disease. | Ferrisi R et al. | β | 2023 | β |
| Design, synthesis and biological evaluation of novel orthosteric-allosteric ligands of the cannabinoid receptor type 2 (CB<sub>2</sub>R). | Ferrisi R et al. | β | 2022 | β |
| Exploration of Multiverse Activities of Endocannabinoids in Biological Systems. | Behl T et al. | β | 2022 | β |
| "The Two Sides of the Same Coin"-Medical Cannabis, Cannabinoids and Immunity: Pros and Cons Explained. | Khoury M et al. | β | 2022 | β |
| Anti-Inflammatory Activity of a CB2 Selective Cannabinoid Receptor Agonist: Signaling and Cytokines Release in Blood Mononuclear Cells. | Capozzi A et al. | β | 2021 | β |
| Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies. | Finn DP et al. | β | 2021 | β |
| Impairment of Synaptic Plasticity by Cannabis, Ξ<sup>9</sup>-THC, and Synthetic Cannabinoids. | Hoffman AF et al. | β | 2021 | β |
| Cannabinoid Receptors: An Update on Cell Signaling, Pathophysiological Roles and Therapeutic Opportunities in Neurological, Cardiovascular, and Inflammatory Diseases. | Haspula D et al. | β | 2020 | β |
| <i>Cannabis Sativa</i> Revisited-Crosstalk between microRNA Expression, Inflammation, Oxidative Stress, and Endocannabinoid Response System in Critically Ill Patients with Sepsis. | Dinu AR et al. | β | 2020 | β |
| Thymol modulates the endocannabinoid system and gut chemosensing of weaning pigs. | Toschi A et al. | β | 2020 | β |
| Anti-Inflammatory Effects by Pharmacological Inhibition or Knockdown of Fatty Acid Amide Hydrolase in BV2 Microglial Cells. | Tanaka M et al. | β | 2019 | β |
| Brain activity of anandamide: a rewarding bliss? | Scherma M et al. | β | 2019 | β |
| Cannabinoids, Chemical Senses, and Regulation of Feeding Behavior. | Tarragon E et al. | β | 2019 | β |
| Role of the Endocannabinoidome in Human and Mouse Atherosclerosis. | Piscitelli F et al. | β | 2019 | β |
| The onus of cannabinoids in interrupting the molecular odyssey of breast cancer: A critical perspective on UPR<sup>ER</sup> and beyond. | Rahman S et al. | β | 2019 | β |
| Extrasynaptic Neurotransmission Mediated by Exocytosis and Diffusive Release of Transmitter Substances. | Del-Bel E et al. | β | 2018 | β |
| Because difficulty is not the same for everyone: the impact of complexity in working memory is associated with cannabinoid 1 receptor genetic variation in young adults. | Ruiz-Contreras AE et al. | β | 2017 | β |
| Do Cannabinoids Confer Neuroprotection Against Epilepsy? An Overview. | Capasso A | β | 2017 | β |
| Dronabinol increases pain threshold in patients with functional chest pain: a pilot double-blind placebo-controlled trial. | Malik Z et al. | β | 2017 | β |
| Endocannabinoids in arthritis: current views and perspective. | Barrie N et al. | β | 2017 | β |
| N-stearoyltyrosine protects primary cortical neurons against oxygen-glucose deprivation-induced apoptosis through inhibiting anandamide inactivation system. | Cui HJ et al. | β | 2017 | β |
| Role of Endocannabinoids on Sweet Taste Perception, Food Preference, and Obesity-related Disorders. | Tarragon E et al. | β | 2017 | β |
| The endocannabinoid system in pain and inflammation: Its relevance to rheumatic disease. | Barrie N et al. | β | 2017 | β |
| Dissecting the Signaling Pathways Involved in the Crosstalk between Metabotropic Glutamate 5 and Cannabinoid Type 1 Receptors. | Olmo IG et al. | β | 2016 | β |
| FAAH Gene Variation Moderates Stress Response and Symptom Severity in Patients with Posttraumatic Stress Disorder and Comorbid Alcohol Dependence. | Spagnolo PA et al. | β | 2016 | β |
| For whom the endocannabinoid tolls: Modulation of innate immune function and implications for psychiatric disorders. | Henry RJ et al. | β | 2016 | β |
| Involvement of endocannabinoid neurotransmission in the bed nucleus of stria terminalis in cardiovascular responses to acute restraint stress in rats. | Gomes-de-Souza L et al. | β | 2016 | β |
| Medicinal Chemistry, Pharmacology, and Potential Therapeutic Benefits of Cannabinoid CB2 Receptor Agonists. | Aghazadeh Tabrizi M et al. | β | 2016 | β |
| The Endocannabinoid System in the Retina: From Physiology to Practical and Therapeutic Applications. | Schwitzer T et al. | β | 2016 | β |
| A comprehensive patents review on cannabinoid 1 receptor antagonists as antiobesity agents. | Sharma MK et al. | β | 2015 | β |
| Cerebellar endocannabinoids: retrograde signaling from purkinje cells. | Marcaggi P | β | 2015 | β |
| Gestation Related Gene Expression of the Endocannabinoid Pathway in Rat Placenta. | Vaswani K et al. | β | 2015 | β |
| Metabolomic and Gene Expression Profiles Exhibit Modular Genetic and Dietary Structure Linking Metabolic Syndrome Phenotypes in Drosophila. | Williams S et al. | β | 2015 | β |
| Monoacylglycerol lipase (MGLL) polymorphism rs604300 interacts with childhood adversity to predict cannabis dependence symptoms and amygdala habituation: Evidence from an endocannabinoid system-level analysis. | Carey CE et al. | β | 2015 | β |
| Potential Therapeutical Contributions of the Endocannabinoid System towards Aging and Alzheimer's Disease. | Bonnet AE et al. | β | 2015 | β |
| The role of cannabinoids in regulation of nausea and vomiting, and visceral pain. | Malik Z et al. | β | 2015 | β |
| The Role of the Brain's Endocannabinoid System in Pain and Its Modulation by Stress. | Corcoran L et al. | β | 2015 | β |
| Angiotensin II-induced activation of central AT1 receptors exerts endocannabinoid-mediated gastroprotective effect in rats. | Gyires K et al. | β | 2014 | β |
| A role for the endocannabinoid system in exercise-induced spatial memory enhancement in mice. | Ferreira-Vieira TH et al. | β | 2014 | β |
| Cannabinoid receptor antagonists and fatty acids alter endocannabinoid system gene expression and COX activity. | Kim J et al. | β | 2014 | β |
| Cannabis for inflammatory bowel disease. | Naftali T et al. | β | 2014 | β |
| Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CBβ and CBβ receptors. | Desroches J et al. | β | 2014 | β |
| Endocannabinoid signaling and food addiction. | D'Addario C et al. | β | 2014 | β |
| Endocannabinoid signalling in neuronal migration. | Zhou Y et al. | β | 2014 | β |
| Increased placental expression of cannabinoid receptor 1 in preeclampsia: an observational study. | FΓΌgedi G et al. | β | 2014 | β |
| Prospective therapeutic agents for obesity: molecular modification approaches of centrally and peripherally acting selective cannabinoid 1 receptor antagonists. | Sharma MK et al. | β | 2014 | β |
| The endocannabinoid system: directing eating behavior and macronutrient metabolism. | Watkins BA et al. | β | 2014 | β |
| The influence of cannabinoids on generic traits of neurodegeneration. | Fagan SG et al. | β | 2014 | β |
| What we know and do not know about the cannabinoid receptor 2 (CB2). | Malfitano AM et al. | β | 2014 | β |
| A neuroplasticity hypothesis of chronic stress in the basolateral amygdala. | Boyle LM | β | 2013 | β |
| Bad trip due to anticholinergic effect of cannabis. | Mangot AG | β | 2013 | β |
| Inhibition of fatty acid amide hydrolase activates Nrf2 signalling and induces heme oxygenase 1 transcription in breast cancer cells. | Li H et al. | β | 2013 | β |
| Liquid chromatography-tandem mass spectrometry analysis of free and esterified fatty acid N-acyl ethanolamines in plasma and blood cells. | Balvers MG et al. | β | 2013 | β |
| Non-psychotropic analgesic drugs from the endocannabinoid system: "magic bullet" or "multiple-target" strategies? | Starowicz K et al. | β | 2013 | β |
| Quantitative metabolic profiling of lipid mediators. | Balgoma D et al. | β | 2013 | β |
| Sensory gating, cannabinoids and schizophrenia. | Dissanayake DW et al. | β | 2013 | β |
| The endocannabinoid system in advanced liver cirrhosis: pathophysiological implication and future perspectives. | Baldassarre M et al. | β | 2013 | β |
| The Endocannabinoid System in the Postimplantation Period: A Role during Decidualization and Placentation. | Fonseca BM et al. | β | 2013 | β |
| The neuroprotective role of endocannabinoids against chemical-induced injury and other adverse effects. | Zogopoulos P et al. | β | 2013 | β |
| The role of endocannabinoids in pain modulation. | Zogopoulos P et al. | β | 2013 | β |
| The role of endocannabinoids in pregnancy. | Chan HW et al. | β | 2013 | β |
| Tolerance to hypophagia induced by prolonged treatment with a CB1 antagonist is related to the reversion of anorexigenic neuropeptide gene expression in the hypothalamus. | Rorato R et al. | β | 2013 | β |
| Assay and inhibition of diacylglycerol lipase activity. | Johnston M et al. | β | 2012 | β |
| Evidence for bidirectional endocannabinoid transport across cell membranes. | Chicca A et al. | β | 2012 | β |
| Psychopharmacology of the endocannabinoids: far beyond anandamide. | Pamplona FA et al. | β | 2012 | β |
| Type-1 cannabinoid receptor signaling in neuronal development. | Gaffuri AL et al. | β | 2012 | β |
| Anandamide exerts its antiproliferative actions on cholangiocarcinoma by activation of the GPR55 receptor. | Huang L et al. | β | 2011 | β |
| Atheroprotection via cannabinoid receptor-2 is mediated by circulating and vascular cells in vivo. | Hoyer FF et al. | β | 2011 | β |
| Cannabis sativa and the endogenous cannabinoid system: therapeutic potential for appetite regulation. | Farrimond JA et al. | β | 2011 | β |
| Control of striatal signaling by g protein regulators. | Xie K et al. | β | 2011 | β |
| DAGL-dependent endocannabinoid signalling: roles in axonal pathfinding, synaptic plasticity and adult neurogenesis. | Oudin MJ et al. | β | 2011 | β |
| Effect of the Cannabinoid Receptor-1 antagonist SR141716A on human adipocyte inflammatory profile and differentiation. | Murumalla R et al. | β | 2011 | β |
| Hepatic stellate cells and innate immunity in alcoholic liver disease. | Suh YG et al. | β | 2011 | β |
| Pharmacogenetics of new analgesics. | LΓΆtsch J et al. | β | 2011 | β |
| Recent advances in the understanding of the role of the endocannabinoid system in liver diseases. | Huang L et al. | β | 2011 | β |
| Update on the endocannabinoid system as an anticancer target. | Malfitano AM et al. | β | 2011 | β |
| Activation of TRPC6 channels promotes endocannabinoid biosynthesis in neuronal CAD cells. | Bardell TK et al. | β | 2010 | β |
| Anandamide potentiation of miniature spontaneous excitatory synaptic transmission is mediated via IP3 pathway. | Sang N et al. | β | 2010 | β |
| Aspirin-triggered lipoxin induces CB1-dependent catalepsy in mice. | Pamplona FA et al. | β | 2010 | β |
| Docosahexaenoic acid and eicosapentaenoic acid are converted by 3T3-L1 adipocytes to N-acyl ethanolamines with anti-inflammatory properties. | Balvers MG et al. | β | 2010 | β |
| Effects of caffeine on striatal neurotransmission: focus on cannabinoid CB1 receptors. | Rossi S et al. | β | 2010 | β |
| Endogenous cannabinoid signaling is required for voluntary exercise-induced enhancement of progenitor cell proliferation in the hippocampus. | Hill MN et al. | β | 2010 | β |
| Reduced expression of glutamate receptors and phosphorylation of CREB are responsible for in vivo Delta9-THC exposure-impaired hippocampal synaptic plasticity. | Fan N et al. | β | 2010 | β |
| The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase alpha mediates retrograde suppression of synaptic transmission. | Tanimura A et al. | β | 2010 | β |
| The endocannabinoid signaling system: a marriage of PUFA and musculoskeletal health. | Watkins BA et al. | β | 2010 | β |
| The endocannabinoid system: its roles in energy balance and potential as a target for obesity treatment. | AndrΓ© A et al. | β | 2010 | β |
| Adaptations of striatal endocannabinoid system during stress. | Rossi S et al. | β | 2009 | β |
| Analysis of endocannabinoids, their congeners and COX-2 metabolites. | Kingsley PJ et al. | β | 2009 | β |
| Candidate genes for cannabis use disorders: findings, challenges and directions. | Agrawal A et al. | β | 2009 | β |
| Changes in the endocannabinoid system may give insight into new and effective treatments for cancer. | Alpini G et al. | β | 2009 | β |
| Development and validation of a quantitative method for the determination of 12 endocannabinoids and related compounds in human plasma using liquid chromatography-tandem mass spectrometry. | Balvers MG et al. | β | 2009 | β |
| Dynamic regulation of the endocannabinoid system: implications for analgesia. | Sagar DR et al. | β | 2009 | β |
| Endocannabinoid-mediated control of synaptic transmission. | Kano M et al. | β | 2009 | β |
| Integration of endocannabinoid signaling into the neural network regulating stress-induced activation of the hypothalamic-pituitary-adrenal axis. | Gorzalka BB et al. | β | 2009 | β |
| Mechanisms of non-opioid analgesics beyond cyclooxygenase enzyme inhibition. | Hamza M et al. | β | 2009 | β |
| Tolerance to non-opioid analgesics in PAG involves unresponsiveness of medullary pain-modulating neurons in male rats. | Tortorici V et al. | β | 2009 | β |
| Adaptations in endocannabinoid signaling in response to repeated homotypic stress: a novel mechanism for stress habituation. | Patel S et al. | β | 2008 | β |
| Anandamide inhibits cholangiocyte hyperplastic proliferation via activation of thioredoxin 1/redox factor 1 and AP-1 activation. | DeMorrow S et al. | β | 2008 | β |
| A potential function of endocannabinoids in the selection of a navigation strategy by rats. | Rueda-Orozco PE et al. | β | 2008 | β |
| Cannabinoid receptor-mediated translocation of NO-sensitive guanylyl cyclase and production of cyclic GMP in neuronal cells. | Jones JD et al. | β | 2008 | β |
| Cannabinoids as potential new therapy for the treatment of gliomas. | Parolaro D et al. | β | 2008 | β |
| Cannabinoids reduce granuloma-associated angiogenesis in rats by controlling transcription and expression of mast cell protease-5. | De Filippis D et al. | β | 2008 | β |
| Carbamoyl tetrazoles as inhibitors of endocannabinoid inactivation: a critical revisitation. | Ortar G et al. | β | 2008 | β |
| Cyclooxygenase-2 in synaptic signaling. | Yang H et al. | β | 2008 | β |
| Differential role of the hippocampal endocannabinoid system in the memory consolidation and retrieval mechanisms. | De Oliveira Alvares L et al. | β | 2008 | β |
| Distribution and function of monoacylglycerol lipase in the gastrointestinal tract. | Duncan M et al. | β | 2008 | β |
| Endocannabinoid 2-arachidonoylglycerol protects neurons by limiting COX-2 elevation. | Zhang J et al. | β | 2008 | β |
| Endocannabinoids in the retina: from marijuana to neuroprotection. | Yazulla S | β | 2008 | β |
| Endocannabinoids: synthesis and degradation. | Di Marzo V | β | 2008 | β |
| Endogenous Bioactive Lipids and the Regulation of Conventional Outflow Facility. | Wan Z et al. | β | 2008 | β |
| Immunohistochemical description of the endogenous cannabinoid system in the rat cerebellum and functionally related nuclei. | SuΓ‘rez J et al. | β | 2008 | β |
| Mass-spectrometric identification of anandamide and 2-arachidonoylglycerol in nematodes. | Lehtonen M et al. | β | 2008 | β |
| Modulation of the anti-nociceptive effects of 2-arachidonoyl glycerol by peripherally administered FAAH and MGL inhibitors in a neuropathic pain model. | Desroches J et al. | β | 2008 | β |
| [Neuropsychopharmacology of delta-9-tetrahydrocannabinol]. | Costentin J | β | 2008 | β |
| Pharmacological evidence for the involvement of diacylglycerol lipase in depolarization-induced endocanabinoid release. | Hashimotodani Y et al. | β | 2008 | β |
| Regulation of endocannabinoid signaling by stress: implications for stress-related affective disorders. | Gorzalka BB et al. | β | 2008 | β |
| Selective CB2 up-regulation in women affected by endometrial inflammation. | Iuvone T et al. | β | 2008 | β |
| Tetrahydrolipstatin analogues as modulators of endocannabinoid 2-arachidonoylglycerol metabolism. | Ortar G et al. | β | 2008 | β |
| The endocannabinoid 2-arachidonoylglycerol is responsible for the slow self-inhibition in neocortical interneurons. | Marinelli S et al. | β | 2008 | β |
| Attenuation of allergic contact dermatitis through the endocannabinoid system. | Karsak M et al. | β | 2007 | β |
| Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis. | Benito C et al. | β | 2007 | β |
| Cannabinoid CB1 receptor stimulation affords neuroprotection in MPTP-induced neurotoxicity by attenuating S100B up-regulation in vitro. | Iuvone T et al. | β | 2007 | β |
| Endocannabinoid regulation of matrix metalloproteinases: implications in ischemic stroke. | Mukhopadhyay S et al. | β | 2007 | β |
| Endocannabinoids and related N-acylethanolamines in the control of appetite and energy metabolism: emergence of new molecular players. | Lambert DM et al. | β | 2007 | β |
| Endocannabinoid system and synaptic plasticity: implications for emotional responses. | Viveros MP et al. | β | 2007 | β |
| Identification of endocannabinoids and related compounds in human fat cells. | Gonthier MP et al. | β | 2007 | β |
| Motor effects of delta 9 THC in cerebellar Lurcher mutant mice. | Lorivel T et al. | β | 2007 | β |
| Opposing actions of endocannabinoids on cholangiocarcinoma growth: recruitment of Fas and Fas ligand to lipid rafts. | DeMorrow S et al. | β | 2007 | β |
| Rimonabant: the role of endocannabinoid type 1 receptor antagonism in modulating the weight and lipid profile of obese patients. | Dibble CT et al. | β | 2007 | β |
| Role of endocannabinoids in regulating drug dependence. | Parolaro D et al. | β | 2007 | β |
| Temporal variation in CB2R levels following T lymphocyte activation: evidence that cannabinoids modulate CXCL12-induced chemotaxis. | Coopman K et al. | β | 2007 | β |
| The inhibition of monoacylglycerol lipase by URB602 showed an anti-inflammatory and anti-nociceptive effect in a murine model of acute inflammation. | Comelli F et al. | β | 2007 | β |
| The role of diacylglycerol lipase in constitutive and angiotensin AT1 receptor-stimulated cannabinoid CB1 receptor activity. | Turu G et al. | β | 2007 | β |
| The role of the hippocampus in mediating emotional responses to nicotine and cannabinoids: a possible neural substrate for functional interactions. | Viveros MP et al. | β | 2007 | β |
| Cannabinoid receptor agonist-induced apoptosis of human prostate cancer cells LNCaP proceeds through sustained activation of ERK1/2 leading to G1 cell cycle arrest. | Sarfaraz S et al. | β | 2006 | β |
| Cannabinoids, opioids and eating behavior: the molecular face of hedonism? | Cota D et al. | β | 2006 | β |
| Cannabis and cardiotoxicity. | Karch SB | β | 2006 | β |
| Current issues in organophosphate toxicology. | Costa LG | β | 2006 | β |
| Effects of endocannabinoid neurotransmission modulators on brain stimulation reward. | Vlachou S et al. | β | 2006 | β |
| Endocannabinoid-mediated synaptic plasticity in the CNS. | Chevaleyre V et al. | β | 2006 | β |
| Local interneurons regulate synaptic strength by retrograde release of endocannabinoids. | Beierlein M et al. | β | 2006 | β |
| Presynaptic effects of anandamide and WIN55,212-2 on glutamatergic nerve endings isolated from rat hippocampus. | Cannizzaro C et al. | β | 2006 | β |
| The endocannabinoid system and cardiovascular risk: pathophysiologic role and developing therapeutic interventions. | Sander GE et al. | β | 2006 | β |
| The endocannabinoid system as an emerging target of pharmacotherapy. | Pacher P et al. | β | 2006 | β |
| Inhibitors of fatty acid amide hydrolase reduce carrageenan-induced hind paw inflammation in pentobarbital-treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors. | Holt S et al. | β | 2005 | β |